PLEKHD1

gene
On this page

Also known as UPF0639

Summary

PLEKHD1 (pleckstrin homology and coiled-coil domain containing D1, HGNC:20148) is a protein-coding gene on chromosome 14q24.1, encoding Pleckstrin homology domain-containing family D member 1 (A6NEE1).

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 101 total
  • MANE Select transcript: NM_001161498

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20148
Approved symbolPLEKHD1
Namepleckstrin homology and coiled-coil domain containing D1
Location14q24.1
Locus typegene with protein product
StatusApproved
AliasesUPF0639
Ensembl geneENSG00000175985
Ensembl biotypeprotein_coding
Entrez400224

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron

ENST00000322564, ENST00000556123, ENST00000923232

RefSeq mRNA: 1 — MANE Select: NM_001161498 NM_001161498

CCDS: CCDS53903

Canonical transcript exons

ENST00000322564 — 13 exons

ExonStartEnd
ENSE000012437776952778369527932
ENSE000012437826952718869527332
ENSE000012437896952669769526829
ENSE000012437976952594469526122
ENSE000012438036952422969524322
ENSE000012438206952228369522377
ENSE000014880826952825069531551
ENSE000015496146950173469501825
ENSE000015632196950282769502879
ENSE000016017796950011569500208
ENSE000016236886950087169500947
ENSE000016898516950057769500666
ENSE000017216406948472869485114

Expression profiles

Bgee: expression breadth broad, 81 present calls, max score 76.97.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1290 / max 55.3459, expressed in 35 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1403450.081521
1403460.047412

Top tissues by expression

99 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right hemisphere of cerebellumUBERON:001489076.97gold quality
cerebellumUBERON:000203776.72gold quality
cerebellar cortexUBERON:000212976.68gold quality
cerebellar hemisphereUBERON:000224576.62gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047371.55gold quality
primary visual cortexUBERON:000243664.95gold quality
right lobe of thyroid glandUBERON:000111964.47gold quality
left lobe of thyroid glandUBERON:000112063.74gold quality
thyroid glandUBERON:000204663.58gold quality
metanephros cortexUBERON:001053362.87gold quality
prefrontal cortexUBERON:000045161.93gold quality
superior frontal gyrusUBERON:000266161.14gold quality
skin of legUBERON:000151160.97gold quality
frontal cortexUBERON:000187060.50gold quality
cortex of kidneyUBERON:000122560.43gold quality
zone of skinUBERON:000001459.54gold quality
adult mammalian kidneyUBERON:000008258.41gold quality
dorsolateral prefrontal cortexUBERON:000983458.32gold quality
kidneyUBERON:000211358.25gold quality
right frontal lobeUBERON:000281058.16gold quality
Brodmann (1909) area 9UBERON:001354058.12gold quality
skin of abdomenUBERON:000141657.90gold quality
bone marrow cellCL:000209257.31silver quality
cerebral cortexUBERON:000095657.27gold quality
anterior cingulate cortexUBERON:000983556.79gold quality
ventricular zoneUBERON:000305354.45silver quality
lymph nodeUBERON:000002953.56gold quality
brainUBERON:000095553.10gold quality
granulocyteCL:000009451.24silver quality
olfactory segment of nasal mucosaUBERON:000538650.97gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-137537yes4.63
E-ANND-3yes3.70
E-MTAB-4850no30.08
E-ENAD-27no3.87

Regulation

Is transcription factor: no

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioplekhd1ENSDARG00000091349
mus_musculusPlekhd1ENSMUSG00000066438
rattus_norvegicusPlekhd1ENSRNOG00000038297
caenorhabditis_elegansWBGENE00009292

Paralogs (2): DEF6 (ENSG00000023892), SWAP70 (ENSG00000133789)

Protein

Protein identifiers

Pleckstrin homology domain-containing family D member 1A6NEE1 (reviewed: A6NEE1)

All UniProt accessions (1): A6NEE1

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the PLEKHD1 family.

RefSeq proteins (1): NP_001154970* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001849PH_domainDomain
IPR011993PH-like_dom_sfHomologous_superfamily

Pfam: PF00169

UniProt features (4 total): chain 1, domain 1, coiled-coil region 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NEE1-F182.290.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 503

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 12 (showing top): chr14q24, PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN, GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN, RYBP_TARGET_GENES, SIX1_TARGET_GENES, GSE13306_TREG_VS_TCONV_SPLEEN_UP, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP, GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN, GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN, GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP, GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP, GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

280 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PLEKHD1SLC39A9Q9NUM3620
PLEKHD1A0A087WYV9A0A087WYV9570
PLEKHD1KLHDC10Q6PID8569
PLEKHD1ZSWIM5Q9P217526
PLEKHD1SLC10A1Q14973473
PLEKHD1LRRC3BQ96PB8446
PLEKHD1ZNF404Q494X3414
PLEKHD1FLACC1Q96Q35404
PLEKHD1SPATA18Q8TC71397
PLEKHD1POU2AF2Q8IXP5392
PLEKHD1POU2AF3A8K830386
PLEKHD1ATP6AP1LQ52LC2378
PLEKHD1KLHDC7AQ5VTJ3378
PLEKHD1SUSD6Q92537376
PLEKHD1CCDC177Q9NQR7376

IntAct

3 interactions, top by confidence:

ABTypeScore
PLEKHD1RSL1D1psi-mi:“MI:0915”(physical association)0.400
SYKPLEKHD1psi-mi:“MI:0914”(association)0.350

BioGRID (6): PLEKHD1 (Synthetic Lethality), RSL1D1 (Proximity Label-MS), PLEKHD1 (Affinity Capture-MS), PLEKHD1 (Affinity Capture-MS), TMED5 (Cross-Linking-MS (XL-MS)), PLEKHD1 (Affinity Capture-MS)

ESM2 similar proteins: A0JMK8, A0JMQ7, A0JNT9, A0JP75, A1A600, A2A6T1, A2AUM9, A2BGP7, A6NEE1, A6NI79, A6QNP9, B1WBU8, B2RPU2, B8JK76, B9V5F5, D3YV10, G9G127, P0CB05, P0CF95, P60853, Q32PN7, Q3UP38, Q499E4, Q5JU67, Q5SPX1, Q5U3A8, Q5U4W1, Q5XIA0, Q61043, Q6DIS8, Q6GLX3, Q6P402, Q6PA69, Q6PGZ0, Q6ZP65, Q6ZQ12, Q7TMK6, Q80YT7, Q8BIJ7, Q8BMK0

Diamond homologs: A6NEE1, B1WBU8, B2RPU2, O45420

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

101 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance93
Likely benign3
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

2054 predictions. Top by Δscore:

VariantEffectΔscore
14:69500664:CATG:Cdonor_loss1.0000
14:69500666:TG:Tdonor_loss1.0000
14:69500667:G:GGdonor_gain1.0000
14:69500669:G:GTdonor_loss1.0000
14:69500671:G:GGdonor_gain1.0000
14:69501801:GC:Gdonor_gain1.0000
14:69501802:C:Gdonor_gain1.0000
14:69501807:G:GTdonor_gain1.0000
14:69501808:A:Tdonor_gain1.0000
14:69501815:G:GTdonor_gain1.0000
14:69501815:GGA:Gdonor_gain1.0000
14:69501816:GAG:Gdonor_gain1.0000
14:69502875:GAGAG:Gdonor_gain1.0000
14:69502877:GAG:Gdonor_gain1.0000
14:69502879:GGTA:Gdonor_loss1.0000
14:69502880:G:Adonor_loss1.0000
14:69502881:T:Gdonor_loss1.0000
14:69522271:T:TAacceptor_gain1.0000
14:69522272:G:Aacceptor_gain1.0000
14:69522281:AG:Aacceptor_gain1.0000
14:69522282:GG:Gacceptor_gain1.0000
14:69522282:GGA:Gacceptor_gain1.0000
14:69522364:G:GTdonor_gain1.0000
14:69522375:G:GTdonor_gain1.0000
14:69524318:TGGAG:Tdonor_loss1.0000
14:69524320:G:GTdonor_gain1.0000
14:69524321:AG:Adonor_loss1.0000
14:69524322:GGTG:Gdonor_loss1.0000
14:69524323:G:Adonor_loss1.0000
14:69524324:T:Gdonor_loss1.0000

AlphaMissense

3350 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:69485076:G:CK37N1.000
14:69485076:G:TK37N1.000
14:69485104:T:AW47R1.000
14:69485104:T:CW47R1.000
14:69500141:T:CL59P1.000
14:69500200:C:GH79D1.000
14:69500204:C:AP80H1.000
14:69500916:T:AW127R1.000
14:69500916:T:CW127R1.000
14:69527327:T:CL399P1.000
14:69485069:T:CL35P0.999
14:69485106:G:CW47C0.999
14:69485106:G:TW47C0.999
14:69500116:T:CF51L0.999
14:69500117:T:CF51S0.999
14:69500118:T:AF51L0.999
14:69500118:T:GF51L0.999
14:69500129:A:TK55I0.999
14:69500130:A:CK55N0.999
14:69500130:A:TK55N0.999
14:69500137:T:CF58L0.999
14:69500139:T:AF58L0.999
14:69500139:T:GF58L0.999
14:69500141:T:AL59Q0.999
14:69500141:T:GL59R0.999
14:69500144:T:CL60P0.999
14:69500146:T:GY61D0.999
14:69500149:T:GY62D0.999
14:69500203:C:TP80S0.999
14:69500204:C:GP80R0.999

dbSNP variants (sampled 300 via entrez): RS1000099135 (14:69506819 T>G), RS1000132715 (14:69523746 A>C,G), RS1000147144 (14:69519121 T>C), RS1000225094 (14:69483510 T>G), RS1000246410 (14:69484491 A>G), RS1000289871 (14:69525207 C>A), RS1000336501 (14:69528971 C>T), RS1000347263 (14:69490286 A>G), RS1000422055 (14:69489029 A>G), RS1000503651 (14:69511524 G>T), RS1000506623 (14:69471023 C>T), RS1000538946 (14:69467254 T>C), RS1000554490 (14:69506491 C>T), RS1000591022 (14:69511503 T>A), RS1000656192 (14:69505097 T>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST004362_2Plasma estrone levels in resected estrogen-receptor positive breast cancer2.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007970estrone measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation1
sodium arseniteincreases expression1
Benzo(a)pyreneincreases methylation, decreases methylation1
Malathiondecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.